Syrian healthtech Moadna raises $50,000 in angel funding

A Syrian healthtech startup has closed a small but meaningful early-stage round as it builds out a digital platform for clinics and doctors in one of the region's most underserved markets.

Moadna, founded by Tarek Skheta and Maged Hamdeh, has raised $50,000 from angel investors, putting its valuation at $300,000. The company runs a platform that lets clinics and medical centres handle appointments, patient records, billing, and communications in one place.

The numbers are early-stage, but the traction is real. Moadna now has more than 550 doctors, clinics, and medical centres using its platform, over 8,000 registered users, and more than 3,500 appointments booked to date.

How does it work?

Moadna is built around two core needs: running a clinic and finding a doctor. On the provider side, it gives medical practices a single tool to manage their day-to-day operations, including:

• Appointment scheduling and calendar management
• Patient records and visit tracking
• Billing, revenue, and expense monitoring

For patients, the platform offers digital booking and direct communication with their healthcare providers. Think of it as a practice management system and a patient-facing booking app rolled into one.

Why does it matter?

Syria is not a market that gets much attention from tech investors. That makes this raise notable, even at a small scale. A homegrown startup building real infrastructure for healthcare providers in the country is a meaningful development, and the fact that it has attracted angel funding suggests at least some investors see opportunity there.

The funding will go toward three things: improving the product, strengthening the technical infrastructure, and expanding commercial operations. Moadna is also preparing for a pre-seed round, so this angel raise is a bridge to that next stage.

Healthcare digitisation across the Arab world is still patchy. While markets like Saudi Arabia and the UAE have seen serious investment in health tech, earlier-stage markets have far fewer options. Startups that can build reliable tools for clinics in those markets, and do it affordably, have a lot of room to grow.

The context

Moadna previously took part in Thimar, a startup support programme focused specifically on Syrian founders. That kind of structured support matters in markets where startup ecosystems are still forming and founders have fewer networks to draw on.

The company's next step is a pre-seed round, which would give it the capital to push harder on growth inside Syria and potentially look at regional expansion. For now, the $50,000 raise is a signal that Moadna has enough momentum to bring outside capital in, even at an early stage.